Fethiye Aylin Sungur

Prof. Dr. Fethiye Aylin Sungur


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2000 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
HRHaluk Resat
Haluk Resat
FSFethiye Aylin Sungur
Fethiye Aylin Sungur
MBMaciej Baginski
Maciej Baginski
EBEdward Borowski
Edward Borowski
VAViktorya Aviyente
Viktorya Aviyente

5 July 2021 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Open access
PDF file
MYMerve Yuce
Merve Yuce
ECErdem Cicek
Erdem Cicek
TITugce Inan
Tugce Inan
ADAslihan Basak Dag
Aslihan Basak Dag
OKOzge Kurkcuoglu
Ozge Kurkcuoglu
FSFethiye Aylin Sungur
Fethiye Aylin Sungur
The novel coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) still has serious negative effects on health, social life, and economics. Recently, vaccines from various companies have been urgently approved to control SARS‐CoV‐2 infections. However, any specific antiviral drug has not been confirmed so far for regular treatment. An important target is the main protease (Mpro), which plays a major role in replication of the virus. In this study, Gaussian and residue network models are employed to reveal two distinct potential allosteric sites on Mpro that can be evaluated as drug targets besides the active site. Then, Food and Drug Administration (FDA)‐approved drugs are docked to three distinct sites with flexible docking using AutoDock Vina to identify potential drug candidates. Fourteen best molecule hits for the active site of Mpro are determined. Six of these also exhibit high docking scores for the potential allosteric regions. Full‐atom molecular dynamics simulations with MM‐GBSA method indicate that compounds docked to active and potential allosteric sites form stable interactions with high binding free energy (∆Gbind) values. ∆Gbind values reach −52.06 kcal/mol for the active site, −51.08 kcal/mol for the potential allosteric site 1, and − 42.93 kcal/mol for the potential allosteric site 2. Energy decomposition calculations per residue elucidate key binding residues stabilizing the ligands that can further serve to design pharmacophores. This systematic and efficient computational analysis successfully determines ivermectine, diosmin, and selinexor currently subjected to clinical trials, and further proposes bromocriptine, elbasvir as Mpro inhibitor candidates to be evaluated against SARS‐CoV‐2 infections.

1 May 2001 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
FSFethiye Aylin Sungur
Fethiye Aylin Sungur
VAViktorya Aviyente
Viktorya Aviyente
TSTaner Sen
Taner Sen
IBIvet Bahar
Ivet Bahar

1 January 2011 in Computational and Theoretical Chemistry
Verified
Journal Article
Closed access
MÇMustafa Çoban
Mustafa Çoban
FSFethiye Aylin Sungur
Fethiye Aylin Sungur

24 October 2002 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
FSFethiye Aylin Sungur
Fethiye Aylin Sungur
VAViktorya Aviyente
Viktorya Aviyente
MLManuel F. Ruiz Lopez
Manuel F. Ruiz Lopez

27 June 2024 in Biomacromolecules
Verified
Journal Article
Open access
BKBanu Kocaaga
Banu Kocaaga
TITugce Inan
Tugce Inan
NYNesrin İsIl Yasar
Nesrin İsIl Yasar
CYCan Ege Yalcin
Can Ege Yalcin
FSFethiye Aylin Sungur
Fethiye Aylin Sungur
HAHakan Arslan
Hakan Arslan
Microvascular surgery plays a crucial role in reconnecting micrometer-scale vessel ends. Suturing remains the gold standard technique for small vessels; however, suturing the collapsed lumen of microvessels is challenging and time-consuming, with the risk of misplaced sutures leading to failure. Although multiple solutions have been reported, the emphasis has predominantly been on resolving challenges related to arteries rather than veins, and none has proven superior. In this study, we introduce an innovative solution to address these challenges through the development of an injectable lidocaine-loaded pectin hydrogel by using computational and experimental methods. To understand the extent of interactions between the drug and the pectin chain, molecular dynamics (MD) simulations and quantum mechanics (QM) calculations were conducted in the first step of the research. Then, a series of experimental studies were designed to prepare lidocaine-loaded injectable pectin-based hydrogels, and their characterization was performed by using Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), and rheological analysis. After all the results were evaluated, the drug-loaded pectin-based hydrogel exhibiting self-healing properties was selected as a potential candidate for in vivo studies to determine its performance during operation. In this context, the hydrogel was injected into the divided vessel ends and perivascular area, allowing for direct suturing through the gel matrix. While our hydrogel effectively prevented vasospasm and facilitated micro- and supermicro-vascular anastomoses, it was noted that it did not cause significant changes in late-stage imaging and histopathological analysis up to 6 months. We strongly believe that pectin-based hydrogel potentially enhanced microlevel arterial, lymphatic, and particularly venous anastomoses.